Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
2024 Readers' Choice Awards
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Class of 2025
Hammarskjold High School
Superior Collegiate and Vocational Institute
Westgate Collegiate & Vocational Institute
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Johnson & Johnson
(NY:
JNJ
)
163.70
+0.72 (+0.44%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 18, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Johnson & Johnson
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2025
July 16, 2025
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson Reports Q2 2025 Results; Raises 2025 Outlook
July 16, 2025
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson Elects Daniel Pinto, President, JPMorganChase to its Board of Directors
June 10, 2025
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
May 28, 2025
From
Johnson & Johnson
Via
Business Wire
FDA Panel Reiterates the Cancer Risks of Talc
May 23, 2025
From
Beasley Allen Law Firm
Via
Business Wire
Johnson & Johnson to Participate in the Bernstein’s 41st Annual Strategic Decisions Conference
May 21, 2025
From
Johnson & Johnson
Via
Business Wire
Nachawati Law Group Files New Ovarian Cancer Lawsuits Against Johnson & Johnson After Latest Bankruptcy Ploy Fails
May 15, 2025
From
Nachawati Law Group
Via
Business Wire
Johnson & Johnson to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
May 14, 2025
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson expands efforts to champion the nursing workforce globally
May 08, 2025
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson to Participate in the Bernstein’s 41st Annual Strategic Decisions Conference
April 28, 2025
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson to Participate in the 2025 RBC Capital Markets Global Healthcare Conference
April 16, 2025
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson Announces 63rd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.8%
April 15, 2025
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson Reports Q1 2025 Results
April 15, 2025
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson to Participate in the BofA Securities 2025 Healthcare Conference
April 07, 2025
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson Closes Landmark Intra-Cellular Therapies, Inc. Acquisition to Solidify Neuroscience Leadership
April 02, 2025
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson Announces Expected Closing Date for Intra-Cellular Acquisition
April 01, 2025
From
Johnson & Johnson
Via
Business Wire
Federal Judge Rejects Johnson & Johnson Bankruptcy Strategy, Paving Way for Talc Victims to Seek Justice in Trial Courts
April 01, 2025
From
Beasley Allen Law Firm
Via
Business Wire
Johnson & Johnson to Return to Tort System to Defeat Meritless Talc Claims
March 31, 2025
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson Increases U.S. Investment to More than $55 Billion Over the Next Four Years
March 21, 2025
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
March 05, 2025
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson Announces Darren Snellgrove as Vice President, Investor Relations
March 04, 2025
From
Johnson & Johnson
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Logility Supply Chain Solutions, Inc. (Nasdaq - LGTY), Enfusion, Inc. (NYSE - ENFN), Intra-Cellular Therapies, Inc. (Nasdaq - ITCI), Shutterstock, Inc. (NYSE - SSTK)
February 04, 2025
From
Brodsky & Smith LLC
Via
GlobeNewswire
Johnson & Johnson to Participate in the 45th Annual TD Cowen Healthcare Conference
February 03, 2025
From
Johnson & Johnson
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Logility Supply Chain Solutions, Inc. (Nasdaq - LGTY), Enfusion, Inc. (NYSE - ENFN), Intra-Cellular Therapies, Inc. (Nasdaq - ITCI), Shutterstock, Inc. (NYSE - SSTK)
January 27, 2025
From
Brodsky & Smith LLC
Via
GlobeNewswire
Johnson & Johnson Reports Q4 and Full-Year 2024 Results
January 22, 2025
From
Johnson & Johnson
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Enfusion, Inc. (NYSE - ENFN), Intra-Cellular Therapies, Inc. (Nasdaq - ITCI), H&E Equipment Services, Inc. (Nasdaq - HEES), Shutterstock, Inc. (NYSE - SSTK)
January 21, 2025
From
Brodsky & Smith LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Enfusion, Inc. (NYSE - ENFN), Intra-Cellular Therapies, Inc. (Nasdaq - ITCI), Paycor HCM, Inc. (Nasdaq - PYCR), Accolade, Inc. (Nasdaq - ACCD)
January 13, 2025
From
Brodsky & Smith LLC
Via
GlobeNewswire
Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.
January 13, 2025
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson Announces Quarterly Dividend for First Quarter 2025
January 02, 2025
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
December 12, 2024
From
Johnson & Johnson
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.